Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?

PurposeTo retrospectively elucidate the findings useful in determining the tumor grade of pancreatic neuroendocrine tumors (PNETs) by combined assessment of magnetic resonance (MR) and dynamic computed tomography (CT) images.Materials and methodsEighty-nine patients with PNETs (96 lesions) were included, and classified as G1, 59; G2, 29; and G3, 8 lesions. Image analysis included lesion diameter, shape, enhancement pattern on arterial phase (AP) and delayed phase CT images, calcification, cystic portion, main pancreatic duct dilatation, signal-intensity on T1-, T2-weighted MR images, and appearance of apparent diffusion coefficient (ADC).ResultsSignificant differences among G1, G2, and G3 groups were noted in tumor maximal diameter (p < 0.0001), shape (p < 0.0001), enhancement pattern on AP image (p < 0.0001), cystic portion (p = 0.012), and ADC finding. In multivariate analysis, ADC finding was the independent factor (p = 0.002). The combination findings of low ADC ratio (ADC value of the lesion/ADC value of the parenchyma <0.94), not homogeneous hyper-attenuation, lobulated shape, and hyper-intensity on T2-weighted image were suggestive of G2 or G3 with a probability of 100%. Conversely, all lesions with high ADC ratio and small size (≤25 mm) belonged to the G1 group.ConclusionCombined assessment of MR and CT findings could improve the prediction of tumor grading in PNETs.

[1]  A. Scarpa,et al.  Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. , 2011, Surgery.

[2]  C. Lightdale,et al.  Localization of pancreatic endocrine tumors by endoscopic ultrasonography. , 1992, The New England journal of medicine.

[3]  C. Doglioni,et al.  Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. , 2009, Human pathology.

[4]  N. Fukushima Neuroendocrine Neoplasms of the Pancreas: The PathologicalViewpoint , 2018 .

[5]  P. Capelli,et al.  Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour , 2013, European Radiology.

[6]  Eui Jin Hwang,et al.  Intravoxel Incoherent Motion Diffusion-Weighted Imaging of Pancreatic Neuroendocrine Tumors: Prediction of the Histologic Grade Using Pure Diffusion Coefficient and Tumor Size , 2014, Investigative radiology.

[7]  M. Falconi,et al.  ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors , 2011, Neuroendocrinology.

[8]  Pierre Bedossa,et al.  Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. , 2009, Radiology.

[9]  Michael A Choti,et al.  NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[10]  T. McDade,et al.  Pancreatic neuroendocrine tumors , 2009, Cancer.

[11]  D. Choi,et al.  The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors , 2014, Acta radiologica.

[12]  A. Ferrari,et al.  EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. , 2004, Gastrointestinal endoscopy.

[13]  Hodgkin Lymphoma NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .

[14]  B. Choi,et al.  Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade , 2013, Abdominal Imaging.

[15]  B. Skogseid,et al.  Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution , 2008, Clinical Cancer Research.

[16]  A. Scarpa,et al.  TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system , 2007, Virchows Archiv.

[17]  R. Hruban,et al.  Tumors of the pancreas , 2007 .

[18]  G. Monges,et al.  EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. , 2009, Gastrointestinal endoscopy.

[19]  D. Sahani,et al.  Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. , 2013, Radiology.

[20]  Laura H. Tang,et al.  Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification , 2011, The American journal of surgical pathology.

[21]  J. H. Kim,et al.  Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour , 2015, European Radiology.

[22]  T. Yoshiura,et al.  Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. , 2015, European journal of radiology.

[23]  H. Gouya,et al.  CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. , 2003, AJR. American journal of roentgenology.

[24]  B. Weinhold Epigenetics: The Science of Change , 2006, Virchows Archiv.

[25]  G. Rindi 3. The ENETS Guidelines: The New TNM Classification System , 2010, Tumori.

[26]  Yi Wang,et al.  Diffusion‐weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics , 2011, Journal of magnetic resonance imaging : JMRI.

[27]  E. Paal,et al.  Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[28]  A. Scarpa,et al.  TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. , 2012, Journal of the National Cancer Institute.

[29]  V. Vilgrain,et al.  Endocrine Pancreatic Tumours and Helical CT: Contrast Enhancement Is Correlated with Microvascular Density, Histoprognostic Factors and Survival , 2006, Pancreatology.

[30]  Minhu Chen,et al.  Pancreatic neuroendocrine tumours: correlation between MSCT features and pathological classification , 2014, European Radiology.